RA status | Gene | Differentially methylated loci | Total loci on array | p Value for enrichment | Enrichment factor |
---|---|---|---|---|---|
Hypo | RHOJ | 2 | 9 | 2.16E-05 | 525.33 |
Hypo | MEFV | 2 | 11 | 9.64E-05 | 200.66 |
Hypo | CD93 | 3 | 15 | 2.44E-06 | 200.26 |
Hypo | MYEF2 | 2 | 13 | 0.0001139 | 169.79 |
Hypo | ITGA4 | 3 | 18 | 4.52E-06 | 157.79 |
Hypo | P2RY6 | 2 | 21 | 0.0001567 | 142.51 |
Hypo | AXIN2 | 2 | 37 | 0.0002877 | 102.35 |
Hypo | COL22A1 | 3 | 36 | 2.26E-05 | 83.44 |
Hypo | COL1A1 | 4 | 41 | 1.26E-06 | 79.55 |
Hypo | COL6A1 | 2 | 33 | 0.0006962 | 60.68 |
Hypo | ST14 | 2 | 43 | 0.0009217 | 51.33 |
Hypo | SYNJ2 | 2 | 68 | 0.0026518 | 27.84 |
Hyper | IGSF6 | 3 | 6 | 1.21E-06 | 275.53 |
Hyper | EGF | 2 | 13 | 0.0003606 | 107.08 |
Hyper | ITGB8 | 2 | 13 | 0.0005041 | 84.78 |
Hyper | TNF | 4 | 27 | 2.66E-06 | 71.05 |
Hyper | AKT3 | 2 | 30 | 0.0008412 | 63.26 |
Hyper | MAP3K1 | 2 | 24 | 0.0013940 | 45.92 |
Hyper | PLXNA2 | 3 | 45 | 0.0001585 | 43.66 |
Hyper | TRERF1 | 4 | 50 | 1.49E-05 | 41.35 |
Hyper | FOXO1 | 2 | 32 | 0.0020262 | 36.94 |
Hyper | TIMP2 | 4 | 64 | 5.67E-05 | 28.37 |
Hyper | COL4A1 | 2 | 71 | 0.0035030 | 26.73 |
Hyper | COL4A2 | 5 | 139 | 1.53E-05 | 22.99 |
Hyper | SRPK2 | 2 | 45 | 0.0056023 | 20.18 |
Hyper | ADAM12 | 2 | 52 | 0.0057208 | 19.88 |
Hyper | PTPN14 | 2 | 59 | 0.0080113 | 16.26 |
Hyper | DNMT3A | 2 | 77 | 0.0088166 | 15.35 |
Hyper | CREB5 | 2 | 82 | 0.0142486 | 11.7 |
Hyper | PRKCZ | 2 | 263 | 0.0332803 | 7.22 |
A p value cut-off of <0.05 was used for determining significance.
Hyper, hypermethylated; Hypo, hypomethylated; RA, rheumatoid arthritis.